Raymond Anderson sold $215K of Monopar Therapeutics stock
By AlphaYouPublished Form 4
Anderson Raymond
Reporting filer
Raymond Anderson reported selling 3,142 shares of Monopar Therapeutics for about $215K ($68.35 a share on average). Form 4 filed Nov 5, 2026 lists 8 entries.
See the price move since this trade →
- Disclosed
- Nov 5, 2026
Reported details
8 entries| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Anderson Raymond | 2026-11-02 | M | Exercise or conversion | 1402 | 29.9986 | 6,775 | 3 days | Filed terms
|
| Common Stock | Anderson Raymond | 2026-11-02 | M | Exercise or conversion | 1740 | 30 | 8,515 | 3 days | Filed terms
|
| Common Stock | Anderson Raymond | 2026-11-02 | S | Sale | 840 | 66.16 | 7,675 | 3 days | Filed terms
|
| Common Stock | Anderson Raymond | 2026-11-02 | S | Sale | 600 | 67.06 | 7,075 | 3 days | Filed terms
|
| Common Stock | Anderson Raymond | 2026-11-02 | S | Sale | 200 | 68.68 | 6,875 | 3 days | Filed terms
|
| Common Stock | Anderson Raymond | 2026-11-02 | S | Sale | 1502 | 70.04 | 5,373 | 3 days | Filed terms
|
| Stock Option (derivative) | Anderson Raymond | 2026-11-02 | M | Exercise or conversion | 1402 | 0 | 1,401 | 3 days | Filed terms
|
| Stock Option (derivative) | Anderson Raymond | 2026-11-02 | M | Exercise or conversion | 1740 | 0 | 1,740 | 3 days | Filed terms
|
Common Stock
- Owner
- Anderson Raymond
- Date
- 2026-11-02
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 1402
- Price
- 29.9986
- Following holdings
- 6,775
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F2
- transaction Shares: 1402
- transaction Price Per Share: 29.9986
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 6775
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Anderson Raymond
- Date
- 2026-11-02
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 1740
- Price
- 30
- Following holdings
- 8,515
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F2
- transaction Shares: 1740
- transaction Price Per Share: 30
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 8515
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Anderson Raymond
- Date
- 2026-11-02
- Code
- S
- Action
- Sale
- Quantity
- 840
- Price
- 66.16
- Following holdings
- 7,675
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F2
- transaction Shares: 840
- transaction Price Per Share: 66.16
- id: F4
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 7675
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Anderson Raymond
- Date
- 2026-11-02
- Code
- S
- Action
- Sale
- Quantity
- 600
- Price
- 67.06
- Following holdings
- 7,075
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F2
- transaction Shares: 600
- transaction Price Per Share: 67.06
- id: F5
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 7075
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Anderson Raymond
- Date
- 2026-11-02
- Code
- S
- Action
- Sale
- Quantity
- 200
- Price
- 68.68
- Following holdings
- 6,875
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F2
- transaction Shares: 200
- transaction Price Per Share: 68.68
- id: F6
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 6875
- direct Or Indirect Ownership: D
Common Stock
- Owner
- Anderson Raymond
- Date
- 2026-11-02
- Code
- S
- Action
- Sale
- Quantity
- 1502
- Price
- 70.04
- Following holdings
- 5,373
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F2
- transaction Shares: 1502
- transaction Price Per Share: 70.04
- id: F7
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 5373
- direct Or Indirect Ownership: D
Stock Option (derivative)
- Owner
- Anderson Raymond
- Date
- 2026-11-02
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 1402
- Price
- 0
- Following holdings
- 1,401
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Stock Option
- conversion Or Exercise Price: 29.9986
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F1
- transaction Shares: 1402
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F2
- expiration Date: 2027-09-17
- underlying Security Title: Common Stock
- underlying Security Shares: 1402
- shares Owned Following Transaction: 1401
- direct Or Indirect Ownership: D
Stock Option (derivative)
- Owner
- Anderson Raymond
- Date
- 2026-11-02
- Code
- M
- Action
- Exercise or conversion
- Quantity
- 1740
- Price
- 0
- Following holdings
- 1,740
- Reporting delay
- 3 days
- Filed terms and references
Filed terms
- security Title: Stock Option
- conversion Or Exercise Price: 30
- transaction Date: 2026-11-02
- transaction Form Type: 4
- transaction Code: M
- equity Swap Involved: 0
- id: F2
- transaction Shares: 1740
- transaction Price Per Share: 0
- transaction Acquired Disposed Code: D
- id: F3
- expiration Date: 2028-08-08
- underlying Security Title: Common Stock
- underlying Security Shares: 1740
- shares Owned Following Transaction: 1740
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Anderson Raymond: Director.
- The filing reports a Rule 10b5-1 trading plan.
- F1: This transaction was effected pursuant to a Rule 10b5-1 Plan executed by the reporting person on 05-26-2026.
- F2: On September 18, 2017, the reporting person was granted stock options to purchase up to 4,205 shares of common stock. The options vest 6/42nds at the six-month anniversary of grant date and 1/42nd per month thereafter.
- F3: On August 9, 2018, the reporting person was granted stock options to purchase up to 5,220 shares of common stock. The options vest 20% on January 1, 2019, 20% on April 1, 2019, 20% on July 1, 2019, 20% on October 1, 2019 and 20% on January 1, 2020.
- F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.56 to $66.53, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (7) to this Form 4.
- F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $66.88 to $67.57, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (7) to this Form 4.
- F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.59 to $68.77, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (7) to this Form 4.
- F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.02 to $70.32, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4) through (7) to this Form 4.
Original sources
Prepared automatically from public filing data. Report a correction.